Viewing Study NCT04740827


Ignite Creation Date: 2025-12-25 @ 5:07 AM
Ignite Modification Date: 2026-03-09 @ 1:59 AM
Study NCT ID: NCT04740827
Status: COMPLETED
Last Update Posted: 2023-09-21
First Post: 2021-02-02
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Atogepant for Prophylaxis of Migraine in Participants Who Failed Previous Oral Prophylactic Treatments.
Sponsor: Allergan
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Episodic Migraine View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Episodic migraine View